Infección bacteriana invasiva en lactantes

1. Huebner RE, Mbelle N, Forrest B, Madore DV, Klugman KP. Immunogenicity after one, two or three doses and impact on the antibody response to co administered antigens of a nonavalent pneumococcal conjugate vaccine in infants of Soweto, South Africa. Pediatr Infect Dis J 2002;21:1004-7.

2. Centers for Disease Control and Prevention (CDC). Trends in perinatal group B streptococcal disease—United States, 2000-2006.MMWR Morb Mortal Wkly Rep 2009;58:109-12.

3. Pantell RH, Newman TB, Bernzweig J, Bergman DA, Takayama JI, Segal M, et al. Management and outcomes of care of fever in early infancy. JAMA 2004;291:1203-12.

4. Baker MD, Bell LM. Unpredictability of serious bacterial illness in febrile infants from birth to 1 month of age. Arch Pediatr Adolesc Med 1999;153:508-11.

5. Baker MD, Bell LM, Avner JR. The efficacy of routine outpatient management without antibiotics of fever in selected infants. Pediatrics 1999;103:627-31.

6. Hui C, Neto G, Tsertsvadze A, Yazdi F, Tricco AC, Tsouros S, et al. Diagnosis and management of febrile infants (0-3 months). Evid Rep Technol Assess (Full Rep) 2012;1-297.

7. Gomez B, Mintegi S, Bressan S, Da Dalt L, Gervaix A, Lacroix L, et al. Validation of the “Step-by-Step” approach in the management of young febrile infants. Pediatrics 2016;138.

8. Milcent K, Faesch S, Gras-Le Guen C, Dubos F, Poulalhon C, Badier I, et al. Use of procalcitonin assays to predict serious bacterial infection in young febrile infants. JAMA Pediatr 2016;170:62-9.

9. Aronson PL, Thurm C, Alpern ER, Alessandrini EA, Williams DJ, Shah SS, et al. Variation in care of the febrile young infant <90 days in US pediatric emergency departments. Pediatrics 2014;134:667-77.

10. Centers for Disease Control and Prevention. Recommended childhood immunization schedule—United States, 1995. MMWR Recomm Rep 1995;44:1-9.

11. Centers for Disease Control (CDC). General recommendations on immunization. MMWR Morb Mortal Wkly Rep 1989;38:205-14, 219-27.

12. Centers for Disease Control and Prevention (CDC). Recommended childhood immunization schedule—United States, 2001.MMWR Morb Mortal Wkly Rep 2001;50:7-10, 19.

13. Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E, et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 2006;295:1668-74.

14. Biondi E, Evans R, Mischler M, Bendel-Stenzel M, Horstmann S, Lee V, et al. Epidemiology of bacteremia in febrile infants in the United States. Pediatrics 2013;132:990-6.

15. Greenhow TL, Hung YY, Herz AM. Changing epidemiology of bacteremia in infants aged 1 week to 3 months. Pediatrics 2012;129:e590-6.

16. Greenhow TL, Hung YY, Herz AM, Losada E, Pantell RH. The changing epidemiology of serious bacterial infections in young infants. Pediatr Infect Dis J 2014;33:595-9.

17. Watt K, Waddle E, Jhaveri R. Changing epidemiology of serious bacterial infections in febrile infants without localizing signs. PLoS ONE 2010;5:e12448.

18. Powell EC, Mahajan PV, Roosevelt G, Hoyle JD Jr, Gattu R, Cruz AT, et al. Epidemiology of Bacteremia in Febrile Infants Aged 60 Days and Younger. Ann Emerg Med 2018;71:211-6.

19. Ouchenir L, Renaud C, Khan S, Bitnun A, Boisvert AA, McDonald J, et al. The epidemiology, management, and outcomes of bacterial meningitis in infants. Pediatrics 2017;140:pii: e20170476.

20. Boyer KM. Neonatal group B streptococcal infections. Curr Opin Pediatr 1995;7:13-8.

21. Clinical and Laboratory Standards Institute. M100-S27: performance standards for antimicrobial susceptibility testing: twenty seventh informational supplement. Wayne (PA): CLSI; 2017.

22. Leazer R, Erickson N, Paulson J, Zipkin R, Stemmle M, Schroeder AR, et al. Epidemiology of cerebrospinal fluid cultures and time to detection in term infants. Pediatrics 2017;139.

23. Biondi EA, Mischler M, Jerardi KE, Statile AM, French J, Evans R, et al. Blood culture time to positivity in febrile infants with bacteremia. JAMA Pediatr 2014;168:844-9.

24. Gerber JS, Glas M, Frank G, Shah SS. Streptococcus bovis Infection in young Infants. Pediatr Infect Dis J 2006;25:1069-73.

25. Kennedy GJ, Kavanagh KL, Kashimawo LA, Cripe PJ, Steele RW. An unlikely cause of neonatal sepsis. Clinical Pediatr (Phila) 2015;54:1017-20.

26. Shah SS, Hines EM, McGowan KL. Cerebrospinal fluid enrichment broth cultures rarely contribute to the diagnosis of bacterial meningitis. Pediatr Infect Dis J 2012;31:318-20.

27. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (RED Cap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377-81.

28. Baskin MN, Goh XL, Heeney MM, Harper MB. Bacteremia risk and outpatient management of febrile patients with sickle cell disease. Pediatrics 2013;131:1035-41.

29. Feudtner C, Hays RM, Haynes G, Geyer JR, Neff JM, Koepsell TD. Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services. Pediatrics 2001;107:E99.

30. Feudtner C, Feinstein JA, Zhong W, Hall M, Dai D. Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation. BMC Pediatr 2014;14:199.

31. Kestenbaum LA, Ebberson J, Zorc JJ, Hodinka RL, Shah SS. Defining cerebrospinal fluid white blood cell count reference values in neonates and young infants. Pediatrics 2010;125:257-64.

32. Mahajan P, Kuppermann N, Mejias A, Suarez N, Chaussabel D, Casper TC, et al. Association of RNA biosignatures with bacterial infections in febrile infants aged 60 days or younger. JAMA 2016;316:846-57.